The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Neurointerventional Device Market Research Report 2025

Global Neurointerventional Device Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1903605

No of Pages : 98

Ask Your Query
Synopsis
Neurointerventional surgery is a multi-disciplinary Accreditation Council for Graduate Medical Education (ACGME) accredited and American Medical Association (AMA) recognized medical specialty specializing in minimally invasive image-guided procedures to treat disorders of the brain, head/neck, and spine.
The global Neurointerventional Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Neurointerventional Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Neurointerventional Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Neurointerventional Device include Codman & Shurtleff, Integra Life Sciences, Medtronic, Stryker, Boston Scientific, BrainLab, Elekta, Karl Storz and Micromar, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Neurointerventional Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurointerventional Device.
Report Scope
The Neurointerventional Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neurointerventional Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neurointerventional Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Codman & Shurtleff
Integra Life Sciences
Medtronic
Stryker
Boston Scientific
BrainLab
Elekta
Karl Storz
Micromar
Scopis
SPR Therapeutics
Abbott
Synapse Biomedical
Aesculap （B. Braun）
TeDan Surgical Innovations
Kogent Surgical
Segment by Type
Embolic Coils
Neurovascular Stents (Carotid Stents and Intracranial Stents)
Neurovascular Thrombectomy Devices
Intrasaccular Devices
Embolic Protection Devices
Others
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neurointerventional Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neurointerventional Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Neurointerventional Device Market Overview
1.1 Product Overview and Scope of Neurointerventional Device
1.2 Neurointerventional Device Segment by Type
1.2.1 Global Neurointerventional Device Market Value Comparison by Type (2024-2030)
1.2.2 Embolic Coils
1.2.3 Neurovascular Stents (Carotid Stents and Intracranial Stents)
1.2.4 Neurovascular Thrombectomy Devices
1.2.5 Intrasaccular Devices
1.2.6 Embolic Protection Devices
1.2.7 Others
1.3 Neurointerventional Device Segment by Application
1.3.1 Global Neurointerventional Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Global Neurointerventional Device Market Size Estimates and Forecasts
1.4.1 Global Neurointerventional Device Revenue 2019-2030
1.4.2 Global Neurointerventional Device Sales 2019-2030
1.4.3 Global Neurointerventional Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neurointerventional Device Market Competition by Manufacturers
2.1 Global Neurointerventional Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neurointerventional Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neurointerventional Device Average Price by Manufacturers (2019-2024)
2.4 Global Neurointerventional Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neurointerventional Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurointerventional Device, Product Type & Application
2.7 Neurointerventional Device Market Competitive Situation and Trends
2.7.1 Neurointerventional Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurointerventional Device Players Market Share by Revenue
2.7.3 Global Neurointerventional Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurointerventional Device Retrospective Market Scenario by Region
3.1 Global Neurointerventional Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neurointerventional Device Global Neurointerventional Device Sales by Region: 2019-2030
3.2.1 Global Neurointerventional Device Sales by Region: 2019-2024
3.2.2 Global Neurointerventional Device Sales by Region: 2025-2030
3.3 Global Neurointerventional Device Global Neurointerventional Device Revenue by Region: 2019-2030
3.3.1 Global Neurointerventional Device Revenue by Region: 2019-2024
3.3.2 Global Neurointerventional Device Revenue by Region: 2025-2030
3.4 North America Neurointerventional Device Market Facts & Figures by Country
3.4.1 North America Neurointerventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neurointerventional Device Sales by Country (2019-2030)
3.4.3 North America Neurointerventional Device Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neurointerventional Device Market Facts & Figures by Country
3.5.1 Europe Neurointerventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neurointerventional Device Sales by Country (2019-2030)
3.5.3 Europe Neurointerventional Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurointerventional Device Market Facts & Figures by Country
3.6.1 Asia Pacific Neurointerventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neurointerventional Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Neurointerventional Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neurointerventional Device Market Facts & Figures by Country
3.7.1 Latin America Neurointerventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neurointerventional Device Sales by Country (2019-2030)
3.7.3 Latin America Neurointerventional Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurointerventional Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurointerventional Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neurointerventional Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neurointerventional Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neurointerventional Device Sales by Type (2019-2030)
4.1.1 Global Neurointerventional Device Sales by Type (2019-2024)
4.1.2 Global Neurointerventional Device Sales by Type (2025-2030)
4.1.3 Global Neurointerventional Device Sales Market Share by Type (2019-2030)
4.2 Global Neurointerventional Device Revenue by Type (2019-2030)
4.2.1 Global Neurointerventional Device Revenue by Type (2019-2024)
4.2.2 Global Neurointerventional Device Revenue by Type (2025-2030)
4.2.3 Global Neurointerventional Device Revenue Market Share by Type (2019-2030)
4.3 Global Neurointerventional Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neurointerventional Device Sales by Application (2019-2030)
5.1.1 Global Neurointerventional Device Sales by Application (2019-2024)
5.1.2 Global Neurointerventional Device Sales by Application (2025-2030)
5.1.3 Global Neurointerventional Device Sales Market Share by Application (2019-2030)
5.2 Global Neurointerventional Device Revenue by Application (2019-2030)
5.2.1 Global Neurointerventional Device Revenue by Application (2019-2024)
5.2.2 Global Neurointerventional Device Revenue by Application (2025-2030)
5.2.3 Global Neurointerventional Device Revenue Market Share by Application (2019-2030)
5.3 Global Neurointerventional Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Codman & Shurtleff
6.1.1 Codman & Shurtleff Corporation Information
6.1.2 Codman & Shurtleff Description and Business Overview
6.1.3 Codman & Shurtleff Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Codman & Shurtleff Neurointerventional Device Product Portfolio
6.1.5 Codman & Shurtleff Recent Developments/Updates
6.2 Integra Life Sciences
6.2.1 Integra Life Sciences Corporation Information
6.2.2 Integra Life Sciences Description and Business Overview
6.2.3 Integra Life Sciences Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Integra Life Sciences Neurointerventional Device Product Portfolio
6.2.5 Integra Life Sciences Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Medtronic Neurointerventional Device Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Stryker
6.4.1 Stryker Corporation Information
6.4.2 Stryker Description and Business Overview
6.4.3 Stryker Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Stryker Neurointerventional Device Product Portfolio
6.4.5 Stryker Recent Developments/Updates
6.5 Boston Scientific
6.5.1 Boston Scientific Corporation Information
6.5.2 Boston Scientific Description and Business Overview
6.5.3 Boston Scientific Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Boston Scientific Neurointerventional Device Product Portfolio
6.5.5 Boston Scientific Recent Developments/Updates
6.6 BrainLab
6.6.1 BrainLab Corporation Information
6.6.2 BrainLab Description and Business Overview
6.6.3 BrainLab Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BrainLab Neurointerventional Device Product Portfolio
6.6.5 BrainLab Recent Developments/Updates
6.7 Elekta
6.6.1 Elekta Corporation Information
6.6.2 Elekta Description and Business Overview
6.6.3 Elekta Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Elekta Neurointerventional Device Product Portfolio
6.7.5 Elekta Recent Developments/Updates
6.8 Karl Storz
6.8.1 Karl Storz Corporation Information
6.8.2 Karl Storz Description and Business Overview
6.8.3 Karl Storz Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Karl Storz Neurointerventional Device Product Portfolio
6.8.5 Karl Storz Recent Developments/Updates
6.9 Micromar
6.9.1 Micromar Corporation Information
6.9.2 Micromar Description and Business Overview
6.9.3 Micromar Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Micromar Neurointerventional Device Product Portfolio
6.9.5 Micromar Recent Developments/Updates
6.10 Scopis
6.10.1 Scopis Corporation Information
6.10.2 Scopis Description and Business Overview
6.10.3 Scopis Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Scopis Neurointerventional Device Product Portfolio
6.10.5 Scopis Recent Developments/Updates
6.11 SPR Therapeutics
6.11.1 SPR Therapeutics Corporation Information
6.11.2 SPR Therapeutics Neurointerventional Device Description and Business Overview
6.11.3 SPR Therapeutics Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 SPR Therapeutics Neurointerventional Device Product Portfolio
6.11.5 SPR Therapeutics Recent Developments/Updates
6.12 Abbott
6.12.1 Abbott Corporation Information
6.12.2 Abbott Neurointerventional Device Description and Business Overview
6.12.3 Abbott Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abbott Neurointerventional Device Product Portfolio
6.12.5 Abbott Recent Developments/Updates
6.13 Synapse Biomedical
6.13.1 Synapse Biomedical Corporation Information
6.13.2 Synapse Biomedical Neurointerventional Device Description and Business Overview
6.13.3 Synapse Biomedical Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Synapse Biomedical Neurointerventional Device Product Portfolio
6.13.5 Synapse Biomedical Recent Developments/Updates
6.14 Aesculap （B. Braun）
6.14.1 Aesculap （B. Braun） Corporation Information
6.14.2 Aesculap （B. Braun） Neurointerventional Device Description and Business Overview
6.14.3 Aesculap （B. Braun） Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Aesculap （B. Braun） Neurointerventional Device Product Portfolio
6.14.5 Aesculap （B. Braun） Recent Developments/Updates
6.15 TeDan Surgical Innovations
6.15.1 TeDan Surgical Innovations Corporation Information
6.15.2 TeDan Surgical Innovations Neurointerventional Device Description and Business Overview
6.15.3 TeDan Surgical Innovations Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 TeDan Surgical Innovations Neurointerventional Device Product Portfolio
6.15.5 TeDan Surgical Innovations Recent Developments/Updates
6.16 Kogent Surgical
6.16.1 Kogent Surgical Corporation Information
6.16.2 Kogent Surgical Neurointerventional Device Description and Business Overview
6.16.3 Kogent Surgical Neurointerventional Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Kogent Surgical Neurointerventional Device Product Portfolio
6.16.5 Kogent Surgical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurointerventional Device Industry Chain Analysis
7.2 Neurointerventional Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurointerventional Device Production Mode & Process
7.4 Neurointerventional Device Sales and Marketing
7.4.1 Neurointerventional Device Sales Channels
7.4.2 Neurointerventional Device Distributors
7.5 Neurointerventional Device Customers
8 Neurointerventional Device Market Dynamics
8.1 Neurointerventional Device Industry Trends
8.2 Neurointerventional Device Market Drivers
8.3 Neurointerventional Device Market Challenges
8.4 Neurointerventional Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock